Oruka Therapeutics, Inc.
- Stock
- Ticker ORKA
- ISIN US6876041087
- Nasdaq
Performance, volatility and drawdowns of Oruka Therapeutics, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $3,173. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.2% in 04/2025, measured from the peak in 12/2016. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -30 | -25 | -28 | -34 | -34 | -36 | -50 | -62 |
| EBITDA | -30 | -25 | -28 | -34 | -34 | -36 | -50 | -62 |
| Net income | -26 | -21 | -25 | -30 | -30 | -32 | -41 | -50 |
| Earnings per share | 2.21 | -0.40 | -0.46 | – | – | – | – | – |
| Balance sheet | ||||||||
| Total assets | 396 | 377 | 357 | 509 | 489 | 504 | 1,139 | 1,231 |
| Liabilities | 14 | 12 | 14 | 22 | 17 | 18 | 25 | 34 |
| Equity | 382 | 365 | 344 | 487 | 472 | 487 | 1,115 | 1,197 |
| Cash | 62 | 84 | 65 | 91 | 47 | 50 | 268 | 192 |
| Cash flow | ||||||||
| Operating cash flow | -19 | -21 | -23 | -22 | -23 | -24 | -33 | -44 |
| Capital expenditure | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | 0.0 | -0.1 |
| Free cash flow | -19 | -21 | -23 | -22 | -23 | -24 | -33 | -44 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +56.4%, weakest 2018 at −75.3%. 3 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | – |
| 10 Aug 2026 | – |
| 13 May 2026 | – |
| 12 Mar 2026 | – |
| 12 Nov 2025 | – |
| 11 Aug 2025 | −$0.46 |
| 14 May 2025 | −$0.40 |
| 6 Mar 2025 | $2.21 |
| 13 Nov 2024 | −$1.46 |
| 1 Aug 2024 | −$6.96 |
| 25 Apr 2024 | −$0.14 |
| 1 Feb 2024 | −$0.08 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €5.9bn
- Market cap in trading currency
- $6.50bn
- Enterprise value
- $5.58bn
- P/E
- –
- P/S
- –
- P/B
- 5.43
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -1.9%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$183m
- Net income
- −$153m
- Earnings per share
- –
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -18.1%
- Return on assets
- -12.4%
Balance sheet and cash flow
- Cash
- $920m
- Cash per share
- $13.57
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 29.62
- Book value per share
- $17.65
- Operating cash flow
- −$124m
- Free cash flow
- −$124m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 67.8m
- Volume
- 1.96m
- Avg. volume 3 months
- 955,276
- Relative volume
- 2.1
Price and technicals
- Price
- $95.81
- 1 day
- −1.8%
- 52-week high
- $113.08
- 52-week low
- $26.40
- Distance to 52-week high
- −15.3%
- Distance to 52-week low
- +262.9%
- Distance to 50-day line
- +6.3%
- Distance to 200-day line
- +29.1%
- RSI (14)
- 50
- Volatility 1M
- 66.6%
Performance
- 1 week
- −9.1%
- 1 month
- +18.1%
- 3 months
- −6.5%
- 6 months
- +58.1%
- YTD
- +216.1%
- 1 year
- +239.0%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ORKA performed since 11/2016?
$10,000 grew to $3,173 by 20 Nov 2026, which is −10.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ORKA?
Volatility was 104.7% per year, measured on monthly returns. The largest decline from a peak was −98.2%, with the low in 04/2025.
How does ORKA compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ORKA returned −10.8% at 104.7%. The correlation of monthly returns was 0.16; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.